Ascend Gene & Cell Therapies
Potters Bar
About Ascend Gene & Cell Therapies
Ascend Gene & Cell Therapies supports manufacturing and process development projects from design through to clinical and commercial scales. They partner with biotechnology teams to embed scalable manufacturing in their operations from the beginning. They respond to customer inquiries by phone and contact form.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Total funding: $132.5M
- Funding stage: Early Stage Venture
- Last round: Series A (May 2023)
- Website: ascend-gctx.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Consulting, Manufacturing, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/ascend-gene-cell-therapies-38680 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.